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Abstract
Solitary plasmacytoma of the bone, especially of a single rib, is a rare disease. We present the case of a 44-year-old
Han Chinese man who was diagnosed with a solitary plasmacytoma of the bone located in the right sixth rib. The
patient presented with a 4-year history of continuous pain in the right chest area and moderate fever lasting 7 days. A
chest roentgenogram showed a solitary expanding lesion in the right thorax, and chest computed tomography revealed
an osteolytic tumor in the chest wall. The patient underwent complete en-bloc resection of the chest wall, including the
ribs, muscle, and parietal pleura. Histologically, the resected mass was composed of abundant neoplastic plasma cells, and
the diagnosis was confirmed to be a plasmacytoma of rib. The examination of marrow cells showed 9 % normal plasma
cells among karyocytes without clonal disease. On postoperative day 14, the patient underwent thoracic radiotherapy
with a total dose of 50 Gy. The patient remained asymptomatic during the 6-month follow-up period. Herein, we also
review previous reports on solitary plasmacytomas of the rib. In summary, this report provides further insights for the
diagnosis and effective treatment of this rare disease.
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Background
Solitary plasmacytoma of bone (SPB) is a rare localized
neoplasm that accounts for only 5 % of malignant plasma
cell tumors [1]. SPBs typically occur in the vertebrae or
pelvic bones, with presentation in the rib being less com-
mon [2, 3]. SPBs are characterized by the presence of only
one or two isolated bone lesions with no evidence of dis-
ease dissemination and are generally considered to be cur-
able with surgical resection and radiotherapy [4]. In most
cases, SPBs present as osteolytic lesions of the bone on
chest X-ray [5]. Herein, we report a case of solitary plas-
macytoma of the rib (SPR) with unique clinical features.
Case report
A 44-year-old man visited our clinic complaining of con-
tinuous pain in the right chest area for 4 years and mod-
erate fever for 7 days. He had no history of trauma or
tuberculosis. A chest roentgenogram (Fig. 1a) and chest
computed tomography (CT) (Fig. 2a and b) revealed a
6.11 cm × 9.33 cm, oval opacity in the right side of the
chest, which was highly suspected to be an intra-
thoracic tumor originating from the pleura or rib. Spiral
CT three-dimensional reconstruction showed an osteo-
lytic lesion in the right sixth rib (Fig. 2c and d), and ab-
normally increased uptake of radioisotope around the
right sixth rib was observed in a bone scan (Fig. 1b).
The radiologic features suggested a focal lytic lesion in
the right sixth rib and limited pleura thickening (Fig. 2a
and b). Peripheral blood examination showed no abnor-
malities (Table 1). Therefore, we decided to remove the
lesion via a surgical approach for the treatment and
diagnosis of the tumor. A standard posterolateral thora-
cotomy was performed along the fifth intercostal space.
We completely resected the tumor and the surrounding
fifth and seventh ribs with a safety margin of at least 3 cm.
Adherent parietal pleura at the tumor site was also
resected. During the operation, no pleural dissemination
was found. Reconstruction of the chest wall defect was
accomplished using a tension-free dacron patch (Johnson
& Johnson, New Brunswick, NJ, USA). The gross
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Fig. 1 Preoperative chest roentgenogram and bone scanning examinations. Chest roentgenogram showing a solitary expanding lesion in the
right sixth rib (arrow, a). Abnormally increased uptake of radioisotope in the right sixth rib on a bone scan (b)
Fig. 2 Spiral computed tomography showing more detailed imagery and data. Three-dimensional computed tomographic image of the chest
showing an irregular mass projecting into the thorax (arrow, a, b and c) and a focal lytic lesion in the sixth rib (black arrow, b). Spiral CT 3D
reconstruction showing the absence of the right sixth rib (arrow, d)
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pathology of the resected specimen showed an irregular,
pale, soft, and friable tumor (Fig. 3a). Histological analysis
of the resected tumor revealed abundant neoplastic
plasma cells in the lesion (Fig. 3b). Immunohistochemical
staining of the specimen showed positive staining for
CD38 and CD138 (Fig. 3c and d). No M-protein in the
serum or urine was found by immunoelectrophoresis. A
biopsy of the bone marrow along with aspiration revealed
that normal plasma cells accounted for 9 % of karyocytes,
and these cells expressed CD38, CD138, CD19, and CD45
(Table 1). These characteristics were consistent with a
diagnosis of plasmacytoma, excluding the possibility of
multiple myeloma (MM).
Starting in postoperative day 15, radiation therapy with
a total target dose of 50 Gy (2 Gy/d, 25 days) was ad-
ministered to tissue surrounding the area of the resected
tumor. The patient was followed up at 6 months after
surgery and was relapse-free with no recurrence accord-
ing to a chest CT scan (Fig. 4).
Discussion
SPB accounts for about 5 % of plasmacytomas [1, 6].
SPBs occur more commonly in males than in females, at
an estimated ratio of 2:1 [7], and the median age of pa-
tients is approximately 55 years, which is about 10 years
younger than patients with MM [5]. Thus far, few stud-
ies have compared SPRs with SPBs in other bones. We
conducted an English literature search using the search
terms “solitary plasmacytoma” and “rib” on Pudmed and
found 18 case reports published between 1992 and 2014
[8–25] (Table 2). Among these SPR patients, 14 were
male and four were female (male to female ratio, 3.5:1),
and their ages ranged from 26–75 years (median,
52 years). The ratio of tumor occurrence in right ribs to
left ones was 1.6:1, and the majority of tumors occurred
on the fourth and fifth ribs (56 %).
The clinical presentation of SPR varies significantly. The
most common symptom is pain due to progression of
osteoclasia or oncothlipsis [8, 9, 11, 12, 14, 15, 21, 23, 25],
but some cases are asymptomatic and found based on a
chest mass during physical examinations [13, 14, 17, 19, 20].
Other chief complaints include limb weakness [16, 22],
Horner’s syndrome [24], and axillary lymphadenectasis
[18]. All the reported cases showed osteolytic ribs on
radiologic examination, including 12 cases with a chest
mass [9–14, 17, 19–21, 24, 25] and two with pleural effu-
sion [8, 12]. In our case, CT showed an irregular intratho-
racic mass with heterogeneous density in the right sixth
osteolytic rib with adjacent pleural thickening.
The currently recommended diagnostic criteria [5] for
SPB include the following: (i) clinical and radiological evi-
dence of a single area of bone destruction on skeletal sur-
vey; (ii) histological confirmation of plasma cell histology;
(iii) normal marrow without clonal disease; (iv) absence of
anemia, hypercalcemia, or renal impairment attributable to
myeloma; and (v) absent or low serum or urinary level of
monoclonal protein (called Bence-Jones protein) and pre-
served levels of uninvolved immunoglobulins. Therefore,
the diagnosis of our case was based on the following find-
ings: osteolytic rib observed by imaging, histopathological
Table 1 Summary of laboratory test results
Investigation Levels (normal range)
Blood routine test
White blood cell count 6.21 (3.5–9.5 × 109)
Red blood cell count 4.35 (4.3–5.8 × 1012)
Hemoglobin 130 (130–175 g/l)
Platelet count 427 (125–350 × 109)
Erythrocyte sedimentation rate 6 mm/1st hour
Blood biochemical examination
Urea 5.49 mmol/L (3.2–7.0)
Creatinine 74.1 μmol/L (44–115)
Uric Acid 224 μmol/L (210–430)
Sodium 139 mmol/L (137–147)
Calcium 2.33 mmol/L (2.10–2.60)
Magnesium 0.82 mmol/L (0.8–1.0)
Electrophoresis of proteins and immunoglobulins
Total protein 77.98 g/l (60–80)
Albumin 44.2 g/l (33–55)
Globin 33.78 g/l (15–35)
M-protein (−)
Alfa1-globulin 4.1 % (1.4–2.9)
Alfa2-globulin 12.5 % (7–11)
Beta-globulin 11.3 % (8–13)
Gammab-protein 25 % (9–16)
IgG 1310 mg/dl (751–1560)
IgA 212 mg/dl (82–453)
IgM 164 mg/dl (46–304)
Kappa light chain 1050 mg/dl (629–1350)
Lambda light chain 649 mg/dl (313–723)
K/L 1.62
Kappa light chain (urine) 1.92 mg/dl (0–1.85)
Lambda light chain (urine) <5.0 mg/dl (0–5)
Examination of marrow cell
Pathology: granulocytes, erythrocytes and giant cells are proliferous
and active. Normal plasma cells are 9 % karyocytes. CD38, CD138,
CD19 and CD45 (+), CD13, CD20, CD117,CD28 and CD56 (−).
Chromosome examinations:46,XY (20), no clonal disorder
RB-1 gene : no abnormalities
IgH gene: no abnormalities
TP53 gene: no abnormalities
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evidence of plasmacytoma, and absence of MM features on
bone marrow examination.
Surgical intervention is the first choice of treatment for
SPB, and a complete resection is expected to be curative.
Bataille et al. [1] reported 114 cases of solitary myeloma
and showed that the lowest incidence of progressive dis-
ease was observed in patients with peripheral solitary plas-
macytoma treated with surgery plus an adequate dose of
radiation therapy. Aviles et al. [26] demonstrated that most
patients treated with adequate radiation therapy alone will
develop MM within 3 years. With respect to the radiation
dose, Mendenhall et al. [27] reported that the local failure
rates were 6 and 31 % in patients with a solitary plasmacy-
toma treated with doses of 40 Gy or greater and doses
below 40 Gy, respectively. It is recommended that SPB be
treated with radical radiotherapy, encompassing the tumor
volume shown on magnetic resonance imaging with a
margin of at least 2 cm and treated to a dose of 40 Gy in
20 fractions. For a SPB with a tumor size of >5 cm, a
higher dose of up to 50 Gy in 25 fractions should be con-
sidered [7].
The role of adjuvant chemotherapy in preventing pro-
gression to MM remains unclear. Some reports suggest
that adjuvant chemotherapy does not affect the inci-
dence of conversion from SPB into MM but could delay
its progression to MM [4]. Patients not responsive to
radiotherapy could be treated with chemotherapy, with
a similar approach to that used in the treatment of MM
[7], but the effectiveness of chemotherapy for SPR
remains to be determined. Our patient received a
complete en-bloc resection and postoperative 50 Gy of
radiotherapy, with no relapse at 6 months after surgery,
Fig. 3 Gross specimen and pathological findings. The tumor (arrow) was resected with the surrounding fifth to seventh ribs, with a safety margin
of at least 3 cm (a). Microscopic view shows abundant neoplastic plasma cells (H&E, ×400) (b). Immunohistochemical staining showed that the
specimen is positive for CD38 (c) and CD138 (d)
Fig. 4 Follow-up chest computed tomography scan. No residual tumor or recurrence was found in the lungs (a) or chest wall (b)
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Table 2 Characteristics of solitary plasmacytoma of the rib
Reference Sex Age Symptom Location Radiologic findings Treatment Prognosis
Caffery T,2014 [8] M 33 Chest pain R-5th rib OR and pleural effusion R Relapse-free at 2-year follow-up
Tajima K,2014 [9] M 71 Chest pain,mild dyspnea R-3th rib OR and CWT S Relapse-free for 1.5 years follow-up
Santos VM,2012 [10] F 65 Breathlessness,discrete expectoration R-4th rib OR and CWT Plasmapheresis Pulmonary acute edema for progressive
disease into MM
Lee HY,2012 [11] M 73 Chest pain R-5th rib OR and CWT S + R No mention
Singal R,2011 [12] F 43 Chest pain, coughing R-5th rib OR,CWT,and pleural effusion S Relapse-free for 2.5 years follow-up
Kodate M,2010 [13] M 70 Chest mass R-4th rib OR and CWT S + R + C Relapse-free for 2 years and 9 months follow-up
Pattanayak L,2010 [14] M 60 Chest pain R-4th rib OR and CWT R Remission after 8 months
Ketata W,2009 [15] M 60 Dyspnea, dry cough, chest pain L-first rib OR S + R Remission after 8 months
Palao S,2006 [16] M 32 Progressive symmetrical paraparesis and paresthesias
in feet (demyelinating- polyradiculoneuropathy)
L-3th rib OR S + R Asymptomatic after surgery
Bousnina S,2006 [17] M 52 Chest mass L-6th rib OR and CWT R Remission at 1 year
Wilkinson S,2003 [18] M 35 Axillary-lymphadenopathy (Castleman’s disease) R-10th rib OR S + R Relapse-free at 2-year follow-up
George SM,2002 [19] M 29 Chest mass R-11th rib OR and CWT S No mention
Sato Y,2001 [20] M 46 Chest mass R-5th rib OR and CWT S No mention
Kadokura M,2000 [21] M 44 Left back pain L-7th rib OR and CWT S + C Relapse-free at 2-year follow-up
Mankodi AK,1999 [22] F 26 Distal limb weakness L-6th rib OR S Improvement in symptoms at 6 months
of follow-up
Hirai T,1995 [23] F 72 Chest pain R-5th rib OR S Relapse-free for 1.7 years of follow-up
Carvajal,1994 [24] M 45 Horner’s syndrome L-first rib OR and CWT S + R Relapse-free for 2 years of follow-up
Ikeda T,1992 [25] M 75 Chest pain L-4th rib OR and CWT R Develop into MM











indicating that our surgery plus radiation therapy was
efficacious.
It is generally accepted that patients with SPB have an
indolent course of disease, with a median survival time
of 10.7 years and 5-, 10-, and 20-year survival rates of
75, 52, and 37 %, respectively [5]. However, Warsame et
al. [28] reported that in a study of 127 SPB patients
followed up for 7–28 months (median, 56 months), 85
patients (67 %) progressed to MM and 27 patients
(21 %) died of progression.
Conclusion
In conclusion, SPRs show an earlier average age of onset
and higher male to female incidence ratio than SPBs lo-
cated in other bones, according to the literature review.
SPRs should be considered when confronted with a lytic
tumor of the rib. The treatment is based on surgery and
radiotherapy. SPRs are often resectable, and the progno-
sis is generally good and dominated by the risk of pro-
gression to MM.
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